Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China
· Delayed Price · Currency is CNY 27.74
+0.10 (0.36%)
Apr 28, 2025, 2:45 PM CST
SHA:603882 Revenue
Guangzhou Kingmed Diagnostics Group had revenue of 1.47B CNY in the quarter ending March 31, 2025, a decrease of -20.35%. This brings the company's revenue in the last twelve months to 6.81B, down -17.53% year-over-year. In the year 2024, Guangzhou Kingmed Diagnostics Group had annual revenue of 7.19B, down -15.81%.
Revenue (ttm)
6.81B
Revenue Growth
-17.53%
P/S Ratio
1.87
Revenue / Employee
588.19K
Employees
11,586
Market Cap
12.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.19B | -1.35B | -15.81% |
| Dec 31, 2023 | 8.54B | -6.94B | -44.82% |
| Dec 31, 2022 | 15.48B | 3.53B | 29.58% |
| Dec 31, 2021 | 11.94B | 3.70B | 44.88% |
| Dec 31, 2020 | 8.24B | 2.97B | 56.45% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |